Copyright Reports & Markets. All rights reserved.

Global Vaccines Delivery Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Vaccines Delivery Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biological Vector
      • 1.4.3 Chemical Carrier
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Vaccines Delivery Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Center
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Vaccines Delivery Market Size
    • 2.2 Vaccines Delivery Growth Trends by Regions
      • 2.2.1 Vaccines Delivery Market Size by Regions (2014-2025)
      • 2.2.2 Vaccines Delivery Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Vaccines Delivery Market Size by Manufacturers
      • 3.1.1 Global Vaccines Delivery Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Vaccines Delivery Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Vaccines Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2 Vaccines Delivery Key Players Head office and Area Served
    • 3.3 Key Players Vaccines Delivery Product/Solution/Service
    • 3.4 Date of Enter into Vaccines Delivery Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Vaccines Delivery Market Size by Type (2014-2019)
    • 4.2 Global Vaccines Delivery Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Vaccines Delivery Market Size (2014-2019)
    • 5.2 Vaccines Delivery Key Players in United States
    • 5.3 United States Vaccines Delivery Market Size by Type
    • 5.4 United States Vaccines Delivery Market Size by Application

    6 Europe

    • 6.1 Europe Vaccines Delivery Market Size (2014-2019)
    • 6.2 Vaccines Delivery Key Players in Europe
    • 6.3 Europe Vaccines Delivery Market Size by Type
    • 6.4 Europe Vaccines Delivery Market Size by Application

    7 China

    • 7.1 China Vaccines Delivery Market Size (2014-2019)
    • 7.2 Vaccines Delivery Key Players in China
    • 7.3 China Vaccines Delivery Market Size by Type
    • 7.4 China Vaccines Delivery Market Size by Application

    8 Japan

    • 8.1 Japan Vaccines Delivery Market Size (2014-2019)
    • 8.2 Vaccines Delivery Key Players in Japan
    • 8.3 Japan Vaccines Delivery Market Size by Type
    • 8.4 Japan Vaccines Delivery Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Vaccines Delivery Market Size (2014-2019)
    • 9.2 Vaccines Delivery Key Players in Southeast Asia
    • 9.3 Southeast Asia Vaccines Delivery Market Size by Type
    • 9.4 Southeast Asia Vaccines Delivery Market Size by Application

    10 India

    • 10.1 India Vaccines Delivery Market Size (2014-2019)
    • 10.2 Vaccines Delivery Key Players in India
    • 10.3 India Vaccines Delivery Market Size by Type
    • 10.4 India Vaccines Delivery Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Vaccines Delivery Market Size (2014-2019)
    • 11.2 Vaccines Delivery Key Players in Central & South America
    • 11.3 Central & South America Vaccines Delivery Market Size by Type
    • 11.4 Central & South America Vaccines Delivery Market Size by Application

    12 International Players Profiles

    • 12.1 Becton Dickinson and Company (BD)
      • 12.1.1 Becton Dickinson and Company (BD) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Vaccines Delivery Introduction
      • 12.1.4 Becton Dickinson and Company (BD) Revenue in Vaccines Delivery Business (2014-2019)
      • 12.1.5 Becton Dickinson and Company (BD) Recent Development
    • 12.2 BioCSL
      • 12.2.1 BioCSL Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Vaccines Delivery Introduction
      • 12.2.4 BioCSL Revenue in Vaccines Delivery Business (2014-2019)
      • 12.2.5 BioCSL Recent Development
    • 12.3 Novavax Inc.
      • 12.3.1 Novavax Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Vaccines Delivery Introduction
      • 12.3.4 Novavax Inc. Revenue in Vaccines Delivery Business (2014-2019)
      • 12.3.5 Novavax Inc. Recent Development
    • 12.4 Vaxart Inc.
      • 12.4.1 Vaxart Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Vaccines Delivery Introduction
      • 12.4.4 Vaxart Inc. Revenue in Vaccines Delivery Business (2014-2019)
      • 12.4.5 Vaxart Inc. Recent Development
    • 12.5 Vaxxas
      • 12.5.1 Vaxxas Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Vaccines Delivery Introduction
      • 12.5.4 Vaxxas Revenue in Vaccines Delivery Business (2014-2019)
      • 12.5.5 Vaxxas Recent Development
    • 12.6 Echo Therapeutics
      • 12.6.1 Echo Therapeutics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Vaccines Delivery Introduction
      • 12.6.4 Echo Therapeutics Revenue in Vaccines Delivery Business (2014-2019)
      • 12.6.5 Echo Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Vaccines Delivery market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Vaccines Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vaccines Delivery development in United States, Europe and China.

      The key players covered in this study
      Becton Dickinson and Company (BD)
      BioCSL
      Novavax Inc.
      Vaxart Inc.
      Vaxxas
      Echo Therapeutics
      ...

      Market segment by Type, the product can be split into
      Biological Vector
      Chemical Carrier
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Research Center

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Vaccines Delivery status, future forecast, growth opportunity, key market and key players.
      To present the Vaccines Delivery development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Vaccines Delivery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now